Реакция #2382

ord-6e6b46e6e7624474a5402b0aba237034

Растворители

Условия реакции

Подробные условия
See reaction.notes.procedure_details.

Обработка

  1. 1
    Температураis refluxed under argon atmosphere for 24 hours
  2. 2
    ТемператураAfter cooling
  3. 3
    ДругоеThe insoluble materials are removed by filtration
  4. 4
    Концентрированиеthe ethyl acetate layer is concentrated to dryness under reduced pressure
  5. 5
    workup.ADDITIONTo the residue are added 10% aqueous sodium hydroxide solution and diethyl ether
  6. 6
    ПромывкаThe aqueous layer is washed with diethyl ether
  7. 7
    Температураcooling
  8. 8
    ЭкстракцияThe mixture is extracted with ethyl acetate
  9. 9
    Промывкаthe ethyl acetate layer is washed
  10. 10
    Другоеdried
  11. 11
    Другоеevaporated
  12. 12
    Другоеto remove the solvent
  13. 13
    ДругоеThe residue is purified by silica gel column chromatography (solvent:chloroform:methanol=100:0~20:1)
  14. 14
    Другоеcrystallized from ethyl acetate

Методика

A mixture of 4-tert-butyl-N-{6-[2-(4-cyanophenoxy)ethoxy]-5-(4-methylphenyl)pyrimidin-4-yl}benzensulfonamide (1.31 g), tributyltin azide (1.60 g) and toluene (13 ml) is refluxed under argon atmosphere for 24 hours. After cooling, ethyl acetate and 10% aqueous potassium fluoride solution are added to the reaction solution. The insoluble materials are removed by filtration, and the ethyl acetate layer is concentrated to dryness under reduced pressure. To the residue are added 10% aqueous sodium hydroxide solution and diethyl ether, and the mixture is stirred at room temperature for 20 minutes. The aqueous layer is washed with diethyl ether, and acidified with 10% hydrochloric acid under ice-cooling. The mixture is extracted with ethyl acetate, and the ethyl acetate layer is washed, dried and evaporated to remove the solvent. The residue is purified by silica gel column chromatography (solvent:chloroform:methanol=100:0~20:1), and crystallized from ethyl acetate to give 4-tert-butyl-N-{5-(4-methylphenyl)-6-[2-(4-(5-tetrazolyl)phenoxy)ethoxy]-pyrimidin-4-yl}benzensulfonamide (1.26 g).

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US05728706uspto-grants-1998_03